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ABSTRACT 
BACKGROUND AND OBJECTIVE: 
 The incidence and prevalence of chronic kidney disease is increasing in 
India. CKD stage V is reached earlier in life. Renal transplantation is the best 
choice of treatment for CKD stage V. Living donor kidney transplantation 
represents about 95% of renal transplantations in India. Uninephrectomy for 
kidney donation puts the donor at risk for renal failure and the development of 
glomerular hyper-filtration syndrome. Studies from the West have have 
documented the safety of living kidney donation. There are limited numbers of 
studies from India regarding kidney donors. 
MATERIALS AND METHODS: 
 The voluntary kidney donors of 50 transplant recipients attending the 
Department of Nephrology-Transplant OPD were chosen and enrolled in the study 
after informed consent. The donors had a post nephrectomy period ranging from 
<1 year to 27 years. They were screened for hypertension, proteinuria and renal 
failure. Their attitude toward kidney donation was studied. 
 
RESULTS: 
 39 female donors and 11 male donors were enrolled. Wives were the single 
major group of donors. The mean age of the donors studied was  49 years, with a 
mean post donation period of 6.58 years. Female donors had a mean age at 
donation less than the males. The mean systolic blood pressure was 122.32±13.65 
mmHG and mean diastolic blood pressure was 79.16±9.85 mmHg. The prevalence 
of hypertension among the donors was similar to the population based studies. 
None of the donors had proteinuria. Only one donor had elevation of urea and 
creatinine. The mean time taken by the donors to return to normal life was 4.08 
weeks. All the donors had a positive attitude towards donation. 
CONCLUSION: 
 The donors seem to have no additional prevalence of hypertension as 
compared to the general population. No proteinuria or major deterioration in renal 
function was noted. All the donors had a positive attitude towards kidney donation. 
Living kidney donation appears to be safe in the Indian scenario also. Larger 
prospective studies are needed to confirm this. 
KEYWORDS: 
 Kidney donors, living kidney donation, glomerular hyperfiltration, renal 
transplantation. 
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INTRODUCTION 
Chronic kidney disease is the result of the inexorable and irrecoverable loss 
of nephron number and renal function. This is identified by the decline in 
Glomerular Filtration rate or GFR. The state of health or disease of the kidneys is 
best assessed by estimating the GFR. 
The term chronic renal failure corresponds to a GFR <60 ml/min/m
2
 and 
occurs during stage III to V of chronic kidney disease. The clinical syndrome is 
called uremia and is produced by accumulation of uremic toxins, electrolytes and 
dysregulation of hormones resulting in a systemic inflammation which is an 
independent risk factor for increased mortality. Renal replacement therapy is 
initiated at a GFR <15 ml/min/m
2
. The syndrome of uremia has to be controlled 
and reversed by the initiation of renal replacement therapies, either dialysis or renal 
transplantation.  
The best form of renal replacement therapy is renal transplanation. However 
there is an increasing mismatch between the demand and supply of kidneys for 
transplantation. This led to the increase in living donor transplantations over 
deceased donor transplants. Further expanded criteria for selecting donors and 
kidneys of brain dead patients were accepted to increase the pool of available 
2 
 
kidneys for transplantation. Recent improvements in post transplant graft support 
have made outcomes similar in related and unrelated kidney transplants.   
The most common type of renal transplantation in India is living donor 
transplantation. It has the advantage of immediate availability of kidneys. However 
it involves an operation and removal of a vital organ from a healthy individual. 
Therefore it is obvious that strict selection criteria for donors and recipients are 
followed. The safety of renal donation has been studied and confirmed by many 
studies in the western world. Data from India about renal donors and the safety of 
renal donation are scarce. This study aims to assess the effects of renal donation by 
assessing the renal function in the donors and the impact of renal donation on their 
psychosocial functioning. 
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AIMS OF THE STUDY 
Uninephrectomy for renal donation results in an obvious loss of nephron 
mass. Surgical ablation of kidneys in animals has proven to result in the syndrome 
of glomerular hyper-filtration in the remaining kidney.  
 
This study aims to evaluate kidney donors for the following 
1. Development of systemic hypertension. 
2. Development of proteinuria. 
3. Development of renal failure by estimation of urea and creatinine values. 
 
The quality of life after kidney donation was analysed by the following 
1. Time taken to return to normal activities following surgery 
2. Their attitude about kidney donation 
 
 
  
 
 
REVIEW OF LITERATURE 
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Chronic Kidney disease 
The NKF-KDOQI
1
 (The National Kidney Foundation Kidney Disease 
Outcome Quality Initiative Work Group - 2002) defined Chronic Kidney Disease 
(CKD), identified the stages of the disease and developed practice guidelines.  
It also established criteria for laboratory assessment of chronic kidney 
disease. It correlated the level of kidney function with the complications of CKD 
and stratified the risk for progressive loss of renal function and the risk of 
cardiovascular disease. 
Definition
1 
The operational definition adopted by the Work Group was as follows:
 
The Work Group preferred to use the word ‘kidney’ instead of ‘renal’ to 
simplify communication between the doctors and patients. 
5 
 
Chronic kidney disease included any condition that affected the kidney with 
the potential to cause progressive loss of renal function, or the complications 
arising out of the decreased renal function. Thus irrespective of the diagnosis, 
kidney damage or decreased renal function for 3 or more months was sufficient for 
a diagnosis of CKD. The National Institute of health and clinical excellence 
(NICE) modification-2008 of the K-DOQI 2002 guidelines is as follows:
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Stages of Chronic Kidney Disease 
Stage  GFR  Action Plan * 
1 ≥90 
Diagnosis and treatment. 
Treatment of co-morbid 
conditions, slowing progression, 
CVD risk reduction 
2 60-89 Estimating progression 
3 30-59 
Evaluating and treating 
complications 
4 15-29 
Preparation for kidney 
replacement therapy 
5 
<15 (or 
dialysis) 
Replacement (if uremia present) 
*Includes actions from preceding stages 
 
Indian scenario of CKD 
CKD in India has sporadically been studied previously
2-5
. There were no 
regional or national reports on incidence or prevalence of CKD. The crude and 
age-adjusted incidence rates of ESRD were found out to be 151 and 232 per 
million populations respectively, in a study by Modi GK et al.  
6,7
. Varma PP et al. 
showed the prevalence of reduced glomerular filtration rate and microalbuminuria 
was 13% and 10% respectively in healthy adults
8
. Agarwal et al found low GFR 
0.8% of 4972 persons surveyed in Delhi
10
. These data are in contrast to those in the 
West where CKD occurs in about 12-20% as estimated by NHANES 
11-13
. 
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The CKD Registry of India created in 2005 with the help of the Indian 
society of Nephrology aims to document and study the various aspects of CKD in 
India. 
The 2011 report of the CKD registry of India
14
 noted a total of 63538 reports 
of CKD. Males constituted 70.6% and females 29.4% of the reported cases. The 
mean age for males was 50.7+14.6 years and 48.1 + 14.3 years for females. The 
overall mean age was 50.0 + 14.6 years with an age range of 19 to 98 years. A 
stable trend was observed in the past 6 years with regard to the age and gender 
distribution. In south zone of India, the highest reports of CKD were in the age 
group of 51 to 60 years. This was consistent with the reports from the other three 
zones. 
Stage I CKD was observed in 1.91% cases, stage II in 4.21%, stage III in 
19.73%, stage IV in 23.60% and stage V in 50.55% of cases. This pattern was 
similar in the reports from all four zones of the country. Patients with CKD stages 
III to V constituted 93.88% of the total reported. Thus it is easily seen that CKD 
stage V constitutes the majority of cases and these are the patients who need expert 
care and renal replacement therapy. 
 
8 
 
 
Irrespective of their educational status, 74.2% patients report to 
nephrologists after stage IV CKD. 74.0% patients irrespective of their income 
report to Nephrologists after stage IV CKD. As family income increases the 
patients come earlier to the nephrologists. 
The most common etiology associated with CKD was diabetic nephropathy, 
seen in 30.9% cases. CGN was the second most common etiology identified with 
13.3% cases. The etiologies of CKD showed a similar trend in all four zones of the 
country. 
9 
 
 
 
Renal Transplantation 
CKD patients in India enter into stage V much earlier (42 years) as 
compared to the developed countries (61 years)
22
. Therefore, CKD occurs in the 
prime period of life. This is the age when patients have to earn and secure their 
families. The earlier occurrence of CKD stage V maybe due to delay in starting 
treatment or measures to slow progression of CKD. 
Thus patients in their productive years need a therapy that is cost effective in 
the long run and also provides a better quality of life. In these regards, renal 
10 
 
transplantation has emerged as the therapy of choice for CKD stage V. The costs of 
the transplant procedure and the follow up immunosuppressive therapy remain 
prohibitive for many patients. But they are still somewhat comparable to the costs 
of maintenance hemodialysis. CAPD is a conducive alternative, as it reduces the 
need to travel to hemodialysis centres, but has its own limitations with regard to 
availability and infection control issues for the patient. CKD often affects the poor 
in our country who cannot afford the costs for these procedures. Despite this, 
transplantation should still be considered wherever possible.  
The  first  successful  renal  transplantation  was  performed   between 
identical twins by Joseph Murray and his team, at  the  Peter  Bent  Brigham  
Hospital in Boston, Massachusetts, in  1954. Study of the immune responses to 
allogenic grafts led to the identification and understanding of the the Human 
Leucocyte Antigens (HLA). Recipient T cells identify allograft HLA antigens and 
mount a vigorous immune response to knock out the graft tissue. The development 
of azathioprine as an immunosuppressant made it possible to perform transplants 
between non-identical persons. Azathioprine was used in conjunction with 
corticosteroids. The development of more potent molecules like mycophenolic 
acid, cyclosporine, tacrolimus and monoclonal antibodies has improved acute 
rejection outcomes. The problem of chronic rejection still remains a major issue. 
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Kidney transplants are of 2 major types: 
1. Living donor transplantation. 
2. Deceased donor transplantation.  
The living donors may be classified further as identical twin, biologically 
related and biologically unrelated donors. The biologically unrelated donor pool 
has fast grown over the last decade. This is mainly due to the improvement in graft 
survival in unrelated donation which now approximates that of the HLA matched 
transplant. The biologically unrelated donors may further be classified as 
emotionally related e.g. spouse, friend, etc. or altruistic donor. Spousal donation is 
on the increase in India. There are social issued regarding live kidney donation like 
organ trafficking. Spousal donation reduces the incidence of such malpractices, 
strengthens the marital bond and makes preemptive transplantation possible by 
reducing the waiting period for the kidney. However given the male dominant 
society in India, donation of kidney by women by compulsion must be carefully 
excluded in every case. Living donor transplantation is now more commonly 
practiced in India. 
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Living Donor Transplantation 
In the United States, about 40% of all transplants performed from living 
related donors. It is lesser in Europe and Australia
15
. It is now the commonest form 
of kidney transplantation in India. In addition, many programs will now accept 
living, non-blood-related or distantly related donors (spouses, cousins, uncles, 
aunts, altruistic donors etc.)  Living related kidney donor transplantation is no 
longer controversial. There has been concern for many years about the long-term 
outcome of a healthy donor. In particular, the concerns regarding the possibility of 
long-term renal dysfunction resulting from hyper-filtration in the solitary kidney 
have prompted transplant centers to re-evaluate their living-related donor program. 
Several long-term follow-up studies have not revealed any adverse problems in 
living related donor with a single kidney
16
. The donor mortality risk has shown to 
be less than 0.1%. Life expectancy in the donor remains unaffected. Further studies 
and follow-up of kidney donors are necessary. In view of the shortage of cadaver 
kidneys, transplantation of a graft from a compatible living related donor should be 
considered if there is a suitable donor. Outstanding results with living unrelated 
donors have been obtained.
17
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Expansion of the living donor pool 
As patient and graft survival rates for kidney transplant recipients with living 
unrelated donors have been shown to be equivalent to living related donor 
transplant recipients, a greater willingness by society and the transplant community 
to consider the unrelated donor has emerged. An extension of living nonrelated 
donation is the non-directed kidney donor, an individual who contacts transplant 
centers wishing to donate a kidney for purely altruistic reasons, to no specific 
recipient in particular. Unlike the non-directed kidney donor, two other 
circumstances have been specifically proposed to increase the number of potential 
living donors. The first, a paired exchange program, attempts to identify two 
potential donors who wish to donate to a family or friend but are unable to due to 
blood group incompatibility or a positive cross-match. Two such donors and their 
prospective recipients are then paired, with donor A donating to recipient B and 
donor B donating to recipient A. An extension of this concept is the mixed donor 
exchange in which an incompatible donor donates to the cadaveric waiting list in 
exchange for their paired recipient moving to the top of the deceased donor list in 
their given blood type. These efforts are currently being tested for their equity and 
effect on transplantation rates in small pilot studies. The second circumstance is the 
matched donor in which a prospective recipient pays a monthly fee to a 
coordinating site, which presumably has access to a list of potential parties 
14 
 
interested in donating their kidney. This strategy circumvents the UNOS waiting 
list and currently is under significant criticism from the American Society of 
Transplantation and UNOS. 
Living donor evaluation 
Live donors are usually first-degree relatives who are one or two haplotype 
matched. However, there is good evidence that zero haplotype-matched relatives 
can donate kidneys that provide excellent chance of short- and long-term graft 
survival. Similarly, good results have been reported with emotionally related living 
donors. Most living nonrelated donors are spouses or companions with long-
standing emotional ties. This practice will likely become an important source of 
organs for transplantation. By 1995, about 10% of transplants were from living 
unrelated donors. Initial screening should concentrate on related donors and tissue 
typing should be used to help choose the best potential donor among ABO-
compatible candidates.  
The attitude toward the use of unrelated live donors varies considerably 
among centers. In general, live-donor transplantation is fraught with potential 
psychological problems and it is important to establish that the prospective donor 
has not been subject to family pressure. A very careful psychological evaluation 
will be needed to determine that the motivation to donate the kidney is, indeed, 
15 
 
genuine. HLA genotyping should be used to decide on the most suitable donor if 
there are several family members who are all keen to give a kidney. The initial 
series of tests which include ABO blood group and HLA tissue typing can be 
completed at a brief outpatient visit. Possible live-donor transplantation can then 
be considered with the individuals best matched to the recipient. The living donor 
not only needs a thorough medical evaluation, with particular attention to renal 
function and the urinary tract, but also a renal angiography or magnetic resonance 
angiography to identify vascular or anatomical variation of the kidneys or the 
collecting systems. It is important to ascertain that both kidneys are of normal size 
and configuration and that a donor kidney with a single renal artery can be 
obtained. 
Exclusion criteria for live kidney donors 
 Age <18 or >65 to 70years 
 Significant medical illness (e.g. cardiovascular or pulmonary diseases, recent 
malignancy) 
History of recurrent kidney stones 
 History of thrombosis or thromboembolism 
 Psychiatric contraindications 
16 
 
 Obesity (30% above ideal weight) 
 Hypertension (>140/90 mmHg or necessity for medication) 
 Proteinuria (>250 mg/24 hr) 
 Microscopic hematuria 
 Abnormal glomerular filtration rate (<80 mL/min) 
 Diabetes (abnormal glucose tolerance test or hemoglobulin A1c) 
 Urologic/vascular abnormalities in donor kidneys 
 
Suggested evaluation process for potential live donors 
 Donor screening 
 Educate patient regarding cadaveric and live donation 
 Take family and social history and screen for potential donors 
 Review ABO compatibilities of potential donors 
 Tissue type and cross-match ABO-compatible potential donors 
 Choose primary potential donor with patient and family 
17 
 
 Educate donor regarding process of evaluation and donation 
 Donor evaluation 
 Complete history and physical examination 
 Comprehensive laboratory screening to include  
1. Complete blood count,  
2. Chemistry panel, 
3. human immunodeficiency virus, 
4. very low-density lipoprotein, 
5. hepatitis B and C serology, 
6. cytomegalovirus, 
7.  glucose tolerance test (for diabetic families) 
 Urinalysis, urine culture, pregnancy test (where appropriate) 
 Protein, 24-hr urine collection 
 Creatinine, 24-hr urine collection 
 Chest radiogram, exercise treadmill for patients older than 50 years of age 
18 
 
 Helical computed tomography urogram 
 Psychosocial evaluation 
 Repeat cross-match before transplantation 
Cadaver donor transplantation 
Better quality kidneys are available with the increase in certification of brain 
death. 
18
 Better preservation techniques have been developed. Organ sharing 
programs help to find appropriate recipients
19
. Although there is a slight influence 
of donor age on renal function in transplant recipients, acceptable donors are 
between age 3 to 65 years old and, in some centers, even younger and older donors 
are being considered. There should be no evidence of primary renal disease and no 
generalized viral or bacterial infection. A major consideration is the risk of 
transmitting infection with the allograft to an immunosuppressed recipient. 
Because of the possibilities of HIV transmission, HIV screening should be 
performed. All donors who are confirmed positive for HIV antibody should be 
excluded from donation. Those donors at high risk for HIV infection generally 
should not be accepted for donation because there is a period of seronegativity in 
early HIV infection before antibodies appear. HIV antigen testing should be 
performed in such donors. 
19 
 
Extended criteria donor 
In an effort to improve utilization of cadaveric organs, UNOS has defined 
and established guidelines for the use of organs that have traditionally resulted in 
excellent short-term function but diminished long-term function (extended criteria 
donors, ECD). These kidneys meet ECD criteria if they arise from  
1. donors over the age of 60 or 
2. donor is between the ages of 50 to 59 with atleast two among the 
following criteria: 
a. Cerebrovacular accident as a cause of death 
b. Prior diagnosis of hypertension or diabetes 
c. Serum creatinine greater than 1.5 mg/dL. 
 These donor kidneys provide improved outcomes when compared to 
dialysis for a significant portion of the dialysis population, particularly elderly 
patients and patients with diabetes who generally have poorer outcomes on 
dialysis. Additional attempts to increase the organ donor pool have addressed the 
use of donors who have died by cardiopulmonary arrest rather than brain death, 
termed deceased by cardiac death donors (DCD). 
20 
 
Cadaver donor - Criteria 
 Diagnosis of brain death  
 Preconditions  
o Positive diagnosis of cause of coma (irremediable structural brain 
damage) 
o Comatose patient, on ventilator  
 Exclusions  
o Severe metabolic or endocrine disturbances 
o Drugs  
o Primary hypothermia (<33°C)  
 Tests  
o Apnea (strictly define) 
o Absent brainstem reflexes  
 No preexisting renal disease  
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 No active infection, Tests:  
o HBsAg; 5 antibodies to cytomegalovirus and hepatitis C virus  
o HIV antibodies  
o HIV antigen in high-risk patients  
 
Transplants So Far in Tamil Nadu
24
:  
It is not surprising that kidneys are the most frequently transplanted organs. 
This is due to the fact that kidney transplantation is now a well established 
technique and many centers have come up with the facility. There is also more 
number of patients on the kidney waitlist every year. The cadaver kidneys function 
satisfactorily post transplantation in many cases. Although inferior to living kidney 
donation, for patients with no available donor, cadaveric transplantation is a new 
hope for a better life. It has been studied that the rate of commercial kidney 
donation has been curtailed by the success of the cadaver transplantation 
programme in Tamil Nadu by Georgi Abraham et al.
26
 It is a proud fact that Tamil 
Nadu had a 1.3 per million population in 2011
24
. For a programme that is 
developing and functioning well, this donation rate maybe expected to increase.   
22 
 
So far 53 hospitals were approved for kidney transplantation in Tamil Nadu 
as on 13th February 2012. 
 
 
 
Donors 
From TN
301
Heart 49
Lung 11
Liver 275
Kidney 555
Total 
Major 
organs
890
Heart 
Valve
350
Cornea 476
Skin 1
Total 
Organs
1717
Performance Report : 
From Oct 2008 to Nov 
30, 2012
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Barriers to deceased donor transplantation in Tamil Nadu 
1. Lack of awareness of brain-death concept 
2. Lack of organ donation awareness 
3. Misunderstood concept that renal transplantation is very expensive in the 
long run 
4. False perception of reduced survival after transplantation 
5. Limited availability of state run kidney transplantation centers which 
function at low cost. 
Pre-transplant preservation of the kidney graft 
Effective preservation of the kidney is an integral part of a kidney 
transplantation program and has evolved on the basis of known principles of 
preservation because of a need for longer storage of kidneys
20
. The ability to 
preserve kidneys provides time for tissue typing and cross-matching and the 
selection of the most appropriate recipients for a particular donor on the basis of 
matching, as well as the preparation of the patients selected, who often may need 
dialysis before transplantation, and, finally, the transport of the kidneys to a center 
where an appropriately matched recipient may be awaiting a transplant. The target 
is to achieve a core temperature of 0ºC. 
24 
 
Commonly used methods: 
1. Continuous perfusion with oxygenated colloid solution. 
2. Storage in ice after complete flushing with cold solution. 
In general, preservation methods do not affect cadaver renal allograft 
outcome
21
. Storage in ice after flushing is now widely used. It is simple and 
preserves the kidney for 24 hours, and even up to 48 hours with newer approaches 
to preservation. 
Before nephrectomy, the blood in the kidney is flushed out with 
hypothermic solution. This is done through the aorta and renal artery. Many 
different flushing solutions have been used (Collins, citrate, University of 
Wisconsin solution). The aim of these maneuvers is to prevent post-transplant 
acute tubular necrosis. The University of Wisconsin solution has revolutionized the 
preservation of livers and pancreas, but whether it represents an improved method 
of preservation for kidneys has not yet been clearly established. 
When there has been no warm ischemia, kidneys preserved up to 24 hours 
function immediately. However, kidneys stored for more than 24 hours begin to 
function slowly. The delay may even be up to several weeks.                                
As the storage time increases there is a greater risk that some function will be 
permanently lost.                                                                                                       
25 
 
 It has been suggested that for short-term outcome, local use of kidneys with 
poor HLA matching is as good as shared use with good matches. Since 18 to 36 
hours is an adequate time for most units and also allows time for transport of 
kidneys within a region or country, there has been widespread adoption of the 
simple cold-storage technique for preservation. 
The second approach of machine preservation is costly and complex. But it 
is not very beneficial. In this albumin or plasma protein fraction is used. The 
circuit oxygenates the colloid during the perfusion process. Either a pulsatile or a 
continuous flow pattern can be utilized.  Both the temperature and the pressure of 
the perfusate are monitored and the flow is generally kept at 1 to 3 mL per gram of 
kidney per minute. However, normal perfusion characteristics are no guarantee of 
organ viability and function.  
Cadaveric organ transplantation - The Tamil Nadu model 
Certification of brain death has been made compulsory in the 3 medical 
college hospitals in Chennai. This is to promote organ donation after brain death. 
The next process depends on where the harvesting takes place. If it is done in a 
place where only kidney transplantation is done, the other kidney, heart, lung and 
liver are available for other hospitals where the appropriate transplantation facility 
is available. 
26 
 
 There has been a recent interest among non government organizations 
(NGOs) in this area. Now, an organ sharing network has been established and is 
functioning well. All the enlisted hospitals are instructed to update the details of 
the waitlist of patients and the transplantation procedures periodically. There has 
also been a government order
25
 to conduct periodic training programmes and 
workshops to increase the general awareness regarding organ donation. The lack 
awareness about the organ donation programme is by itself a major impediment, 
which has to be overcome. With the passage of time, if this system in TamilNadu 
works successfully, more people may become willing to donate organs once brain 
death is pronounced and thereby more patients on the waitlist for organs will 
benefit. This is particularly true for older patients in whom cadaveric 
transplantation is a reasonable option ahead of live kidney transplantation in view 
of the overall short life expectance post transplantation. Most of the transplant 
facilities are presently available only with the private hospitals. With further 
government interest in this issue, more number of medical colleges may be 
upgraded into transplant centres whereby, even the poor people in India may 
benefit. It has already been shown that renal transplantation in the long run is not 
costlier than maintenance hemodialysis or CAPD, but provides a better life. Thus 
the initial cost of the transplant surgery may also become affordable with the 
27 
 
addition of more state run transplant centers. Listed below are some of the 
organizations taking active interest in organ transplantation across India. 
1. The Narmada   Kidney Foundation 
2. The Foundation for Organ Transplantation and Education- FORTE in 
Bangalore 
3. Organ   Retrieval   Banking Organization - ORBO in New   Delhi 
4. Multi-Organ Harvesting Aid Network–MOHAN in Chennai and   
Hyderabad 
5. Zonal Transplant Co-coordinating   Committee - ZTCC in Mumbai 
6. Delhi Organ Procurement Network and Transplant Education – 
DONATE in Delhi 
Outcomes in kidney transplantation 
In the 1960s and early 1970s, many patients were transplanted when there 
were no supportive facilities if the graft failed. In those days, the high mortality 
was related to uncontrolled infection when excessive immunosuppression was used 
for rejection processes. With improvement in clinical care and use of more specific 
immunosuppression, patient survival has been shown to improve both in the 
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cadaveric and in the living related renal transplant recipients. Mortality at the end 
of the first year is currently less than 5% for living donor and under 10% for 
cadaver donor. Indeed, recent data indicate that patients currently receiving 
cadaver donor transplants generally survive longer than patients treated by dialysis. 
Infectious complications of immunosuppressive therapy and cardiovascular 
diseases are the most important cause of death. Based on UNOS registry data, 
during the first post-transplant year, cardiovascular diseases (26%) and infection 
(24%) were the reasons for dying in cadaver kidney transplant recipients. 
Graft Survival 
Acute rejection is the most frequent cause of graft failure within the first 
year. Although there has been a progressive improvement in patient survival, rates 
of graft survival after cadaver transplant have remained virtually unchanged in the 
1970s and early 1980s. The failure to improve these results is due to the lack of 
more specific forms of immunosuppressive therapy. In the years immediately 
following 1983, there were dramatic gains in cadaver graft survival probably 
related to the introduction of cyclosporine. The overall cadaver graft survival has 
increased from about 65% to about 80% to 85% at 1 year. The race of recipients 
also influenced outcomes. Asian recipients had a better outcome than Caucasians 
who fared better than African Americans. 
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Monozygotic Twins 
Provided that there are no technical mishaps as a result of the operation 
itself, one should expect twin kidney transplants to survive indefinitely without the 
need for immunosuppression . However, there has been a significant incidence of 
recurrent glomerulonephritis when this was the original disease in the recipients. In 
a series of 30 identical-twin transplants followed for up to 27 years, 9 developed 
recurrent nephritis, 1 as late as 16 years after transplantation. Of 41 renal 
transplants between monozygotic twins having recorded by the European Dialysis 
and Transplant Association, 36 were alive with functioning grafts from 1 to 14 
years after transplantation. Two grafts failed from recurrent nephritis, two due to 
de novo glomerulonephritis and one died in a traffic accident. This has been 
considered an indication for continuous low-grade immunosuppression in those 
patients where there is a risk of recurrent disease, but perhaps of greater 
importance is the withholding of transplantation until the original disease is 
completely quiescent. 
HLA Identical Siblings 
The HLA identical sibling transplant is ideal and there have been recent 
reports of 3-year graft survival rates of 90% to 95% in such patients. 
Immunosuppression is still necessary since rejection does occur in a substantial 
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number of patients and may even occasionally result in loss of a graft from 
rejection
27
. These rejection episodes no doubt reflect recognition of, or 
sensitization to, minor histocompatibility antigens in the donor or to genetic 
recombination at the HLA-DR locus. As excellent results are obtained with 
azathioprine and prednisone, this would seem to still be the immunosuppressive 
therapy of choice at this time, in view of the nephrotoxicity associated with 
cyclosporine. However, some centers cover the recipient with cyclosporine for 
several months in case of unexpected rejection and then taper and discontinue the 
drug after 4 to 6 months. Steroids can usually be discontinued after 1 or 2 years if 
renal function is stable, although withdrawal of steroids should be done very 
cautiously over a period of at least 6 months. 
HLA Non-identical Parent to Child or Siblings 
A transplant may be performed between a patient and a child who will differ 
for one HLA haplotype or between the two siblings who differ either for one or 
both HLA haplotypes. The results of transplantation were related to the degree of 
HLA disparity, that is, two haplotype-disparate pairs were less successful than one 
haplotype-disparate pair and both were significantly worse than the results of 
transplantation between HLA identical siblings. However, Cyclosporine treatment 
and donor-specific blood transfusion have substantially improved the results of 
transplantation between HLA non-identical family members.  
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Actuarial graft survival is now very close to that achieved for transplantation 
between HLA identical siblings
28
. 
Living Unrelated Transplantation 
A case can be made for the use of emotionally related donors, such as a 
spouse or more distantly related members of the family, such as cousins, and 
perhaps even between very close friends, now that the expectation of a successful 
transplant is quite high
17
. Despite greater histoincompatibility, the survival rates of 
these kidneys are greater than those of cadaveric kidneys. Living donor kidneys 
have performed better probably because the injury by shock in about 10% cadaver 
kidneys which occurred before removal. Living unrelated donors have thus become 
a major source of organ for kidney transplantation
29
.  
Cadaver Transplantation 
The majority of kidneys used for transplantation have been from cadavers. 
Even though there may be variations from center to center, there has been a steady 
improvement in the results of cadaver transplantation in terms of both patient and 
graft survival over the last 10 years
30
. Patient survival is now around 96% at 1 year 
and graft survival is approaching 80%; in selected groups of patients, such as those 
who have been transfused and who are receiving a first graft, graft survival is over 
85%. This improvement in patient survival is due to use of less 
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immunosuppression and, in particular, the use of low-dose steroid protocols. 
Cardiovascular disease has replaced infectious complication as a major cause of 
morbidity and mortality. The results of cadaveric transplantation are now 
approaching a level at which, if there were an adequate supply of cadaver kidneys, 
there probably would be little justification for continuing living related 
transplantation, except when high sensitization of the recipient makes cadaver 
transplant unlikely or impossible. 
Is HLA typing relevant today?  
The improved graft survival, which obviously is due in part to improved 
patient survival, can be attributed to the recognition of the transfusion effect, HLA 
matching, and, more recently, to better immunosuppression. However, controversy 
still exists as to whether matching is of any relevance because of the better results 
achieved with better immunosuppression. Although this question has not been 
resolved, data are gradually accumulating suggesting that matching, and, in 
particular, matching for HLA-DR, does exert the same influence on graft survival 
in patients treated with cyclosporine as with those on conventional 
immunosuppressive therapy. The 6-year half-life of kidney transplants from 
cadaveric donors has been unchanged since the early 1970s.  
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This is in comparison with the 20- to 25-year half-life for the same period in 
HLA-identical sibling transplants, emphasizing the effect of histo-compatibility 
differences on graft survival
30
. 
 
Futuristic aspects of transplantation in India 
The central government has understood the importance of a national and 
regional level body for the implementation, regulation and monitoring of the organ 
transplant programmes. It has come out with a new directive in this purpose. 
1. National Organ Transplant Programme (NOTP). 
2. State   Organ   Procurement   and Distribution   Organization   (SOPDO) 
3. National Organ Procurement and Distribution Organization (NOPDO)  
 
Adaptation of kidney to injury 
Aristotle (384 – 322 B.C.) noted that a single kidney was sufficient to 
sustain life in animals, and that such kidneys were enlarged. The first successful 
nephrectomy was performed by the German surgeon Gustav Simon on August 2, 
1869 in Heidelberg. Prior to this he studied the effects of uninephrectomy in dogs. 
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He found that the size of the remaining kidney increased to 1.5 fold at 20 days post 
nephrectomy
32
. 
  It is clear that the cause of renal failure is loss of functioning nephrons. The 
loss of nephrons is initiated by various insults. When the insult is removed prior to 
a certain threshold, the further loss of nephrons is avoided and there are sufficient 
numbers of healthy nephrons left to carry on the normal function of the kidneys. 
However once the threshold is crossed, the progression of renal failure is a self 
sustained process. 
  This is particularly relevant in chronic kidney disease. The loss of nephrons 
is not localized. The healthy nephrons adjacent to the scarred and defunct nephrons 
adapt structurally and functionally to maintain normal renal function. Thus the 
normal nephrons must overwork to maintain renal function.  
This is more easily observed in persons with normal kidneys and renal 
function, who undergo uninephrectomy for either kidney donation or traumatic 
injuries.  
  This adaptive response of the kidney is identified by an increase in the size 
of the nephrons
33
 and a compensatory increase in the glomerular filtration rate of 
the surviving nephrons. This is called ‘glomerular hyperfiltration’.  
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However like in many physiological compensations, over a period of time, 
glomerulosclerosis and tubular atrophy supervene which further reduces the 
functioning nephron mass and can lead to reduced renal function. 
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Intact nephron hypothesis of Bricker
34
 
In 1960, Bricker postulated the following; 
1. Diseased kidneys reduced nephron mass. 
2. Some of the problems in CKD occur due to changes in body fluids and 
reduced nephron mass. It is not entirely due to change in nephron 
structure. 
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3. The ability to adapt decreases with loss of nephrons. 
4. Excretion for all substances follows an orderly and predictable pattern.  
 
Whole kidney hypertrophic responses 
The earliest changes in the remaining kidney after uninephrectomy are the 
biochemical changes that precede normal cell growth. This is an increase in the 
incorporation of choline, activation of ornithine decarboxylase, increased RNA 
synthesis and suppression of factors inhibiting growth and apoptosis
35
. DNA 
synthesis is increased at 24 hours. It has a maximum of 5 to 10 fold increase that is 
reached within 2 to 3 days. The weight of the kidney was to found increase as early 
as 2 to 3 days. The renal mass continued to increase for 1 to 2 months, by when a 
40 to 50% increase would be expected
35
. Most of the increase in weight would be 
due to hypertrophy of the existing nephrons and only minimally by hyperplasia. 
This is due to the fact that the number of nephrons is determined shortly before 
birth, a phenomenon called ‘Nephron Endowment’.  
 The assessment of renal hypertrophy after nephrectomy in humans has been 
analysed with the help of radiological studies. The volume of the remaining kidney 
increased 27.6 ± 9.7% on an average, at 6 months post donor nephrectomy
36
.        
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In another ultrasound based study, the increase was 19 to 100% 
37
. Computed 
tomography based studies showed an increase in renal cross sectional area of 30 to 
53%.
38
.  However a meta-analysis of these studies could not provide statistically 
significant prognostic data. The hypertrophy is still an observation that is to be 
evaluated for a clinical correlation. 
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Changes in GFR post transplantation 
Glomerular Filtration Rate 
The  GFR  is  the  amount  of  plasma  filtered  through  glomeruli  per  unit  
of  time.  Although the term  can  refer  to  the  function  of  a  single  nephron,  
GFR  most  often  refers  to  the  sum  filtration rate  of  all  functioning  nephrons. 
The normal GFR is approximately 120–130 mL/min/1.73 m2, and it reduces with 
age. 
The level of GFR is accepted as the most useful index of kidney function in 
health and disease. The GFR begins to fall before clinically evident CKD occurs . 
CKD is defined as GFR, 60 mL/min per 1.73 m2 in addition to markers of kidney 
damage. 
The severity of CKD is also determined by the level of GFR. Kidney failure 
is defined as GFR, 15 mL/min per 1.73 m
2
. Kidney failure is associated with 
uremic symptoms and laboratory findings, such as anemia, malnutrition, bone and 
mineral disorders, neuropathy, and decreased quality of life. There is a graded 
relationship between the severity of these signs and symptoms at intermediate 
reductions in GFR in patients with kidney disease.    
          The level of GFR is also associated with progression to kidney failure and 
cardiovascular disease. In addition, drug dosages will need to be adjusted for the 
level of GFR. 
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Measuring GFR 
The gold-standard method to measure GFR is urinary clearance of an ideal 
filtration marker. An ideal filtration marker is one that is (1) freely filtered at the 
glomerulus; (2) present at a stable plasma concentration; and (3) not reabsorbed, 
secreted, or metabolized by the kidney. The ideal filtration marker is inulin. 
However, this is rarely used and alterative markers such as iohexol and iothalamate 
are more commonly used.  
Clearance concept 
              For a substance that is cleared by urinary excretion, the clearance formula 
may be written as:  
                                        CA = UA × V/PA  
where UA is the urinary concentration of A and V is the urine flow rate. The 
term UA × V represents the urinary excretion rate of A. If substance A is freely 
filtered at the glomerulus, then urinary excretion represents the net effects of 
glomerular filtration, tubular reabsorption, and secretion. 
Estimation of GFR in the clinic 
GFR is usually  estimated  from  endogenous  filtration  markers.  The  level  
of  all  known endogenous  filtration  markers  is  determined  by  factors  other  
than GFR,  including  generation from  muscle  mass  and  diet,  tubular  secretion,  
and extra-renal  elimination. GFR  estimating equations  use  the  filtration  marker  
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in  combination  with  demographic  variables  to  overcome some  of  the  
limitations  from  non-GFR  determinants.  The most commonly used filtration 
marker is serum creatinine. The  most  commonly  used  equation  is  the  MDRD  
Study  equation, but  a  more  accurate  equation,  the  CKD-EPI  equation,  has  
recently  been  published. 
Estimating  equations  combine  the  endogenous  filtration  marker(s)  with  
other  variables,  such as  age,  sex,  race,  and  body  size,  as  surrogates  for  non-
GFR  determinants  of  the  filtration markers  and,  therefore,  can  overcome  
some  of  the  limitations  of  the  filtration  marker  alone. An  estimating  equation  
is  derived  using  regression  techniques  to  model  the  observed relationship  
between  the  serum  level  of  the  marker  and  measured  GFR  in  a  study  
population. 
The Cockcroft-Gault formula  
The creatinine clearance or GFR is calculated as: 
      [(140-Age) × Body Weight (in kg)] \ [72 × Serum creatinine (in mg/dL)] 
 
If the patient is female, multiply the above by 0.85 
It was developed in 1973. It is not adjusted for body surface area. 
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Modifications  of  the  Cockcroft  and  Gault  equation  using  ideal  body  
weight  instead  of actual  body  weight  are  sometimes  used  but  have  not  been  
validated. 
 
The MDRD equation 
It was developed in 1999. It  estimates  GFR  adjusted  for body  surface  
area  and  is  more  accurate  than  measured  creatinine  clearance  from  24-hour 
urine  collections  or  estimated  by  the  Cockcroft-Gault  formula.  
 
GFR = 175 × Serum Creatinine 
-1.154
 × age 
-0.203
 
[× 1.212 (if patient is black), × 0.742 (if female)] 
 
 
CKD-EPI Formula 
The  CKD-EPI  equation  is  a  new  equation  to  estimate  GFR  from  
serum  creatinine,  age,  sex,  and race. The  CKD-EPI  equation  was  as  accurate  
as  the  MDRD Study  equation  in  the  subgroup  with  estimated  GFR  less  than  
60  mL/min/1.73  m2  and  substantially more  accurate  in  the  subgroup  with  
estimated  GFR  greater  than  60  mL/min/1.73  m2.  
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The CKD-EPI equation: 
 
Various online e-GFR calculators are available; however, cockroft-gault 
formula continues to be the most frequently used equation due to its ease of 
application. There was a debate as to which formula estimates GFR better in 
persons with single kidney and persons with normal renal function. There was a 
general agreement that the MDRD formula was the closest. However, its 
application in renal donors has been argued, stating that it tends to underestimate 
GFR in normal individuals and post uni-nephrectomy and may falsely classify 
donors under a CKD stage leading to unnecessary hassles. 
Single nephron GFR 
The  single-nephron  GFR  refers  to  the  work  per formed  by  a  single  
functioning  nephron. It can be affected by hemodynamic alterations or structural 
damage.   
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As part of the adaptation of  the  kidney  to  injury,  uninjured  nephrons  
undergo  hypertrophy  and  hyper-filtration  to compensate  for  the  loss  of  
functioning  nephrons  (compensator y  hyperfiltration).  Thus,  total GFR  remains  
relatively  normal  despite  a  decrease  in  functioning  nephrons.  As  such,  the  
GFR is  dependent  on  the  number  of  nephrons  (N)  and  the  single-nephron  
glomerular filtration rate  (SNGFR): 
 
GFR =   N × SNGFR 
 
 
Mechanisms inducing change in GFR 
 Alterations in glomerular hemodynamics after renal mass ablation are due 
the interplay of various vasoactive factors. Vasodilator prostaglandins and 
natriuretic peptides dilate the afferent arterioles. Bradykinin dilates both afferent 
and efferent arterioles. Angiotensin II, vasoconstrictor prostaglandins and 
endothelins constrict efferent arterioles more than afferent arterioles. The nett 
effect of the interplay of various factors is an increase in the ‘Single Nephron 
GFR’ (SNGFR). 
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Renin angiotensin system 
 The effects of the renin angiotensin system in humans are obtained from 
studies showing the effects of pharmacological inhibition of the renin angiotensin 
aldosterone system (RAAS) in preventing the progression of glomerular injury. 
Studies by inducing infarction to produce 5/6 nephrectomy have showed increases 
in the intrarenal renin levels. The study showed that the increases were more 
adjacent to the infarct site
39
.  
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The renoprotective effects of ACE inhibitors and Angiotensin Receptor Blockers 
have been proved in subsequent studies to be due to decreases in intrarenal 
angiotensin levels. 
 
Endothelins 
 Endothelins act via 2 types of receptors ET-A and ET-B. ET-A is found in 
vascular smooth muscle and mediates vasoconstriction and cellular proliferation. 
ET-B is found in the vascular endothelial and renal epithelial cells and functions as 
clearance receptors. Intrarenal endothelin studies by micropuncture techniques are 
yet to be published but current studies show evidence that endothelins are 
increased by chronic infusions of aldosterone and the effects are atleast partially 
mediated by prostaglandins
40
. 
 
Natriuretic peptides 
 Both Atrial and Brain derived natriuretic peptides are found to be increased 
in post nephrectomy state. They mediate increases in GFR in the remaining 
nephrons. They are also vasoactive and dilate the afferent arteriole and constrict 
the efferent arteriole
41
. 
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Eicosanoids 
 Prostaglandin production is increased in the setting of reduced nephron 
mass. Both vasodilatory and vasoconstrictive are produced in the glomerulus. That 
net effect is mediated by the interaction of both the dilator and constrictor types. 
The balance is in favor of vasodilation
42
. 
Nitric oxide 
 Intrarenal effects of nitric oxide are studied from studies of infusions of 
nitric oxide inhibitors. The extremely short half life of Nitric Oxide precludes 
direct intrarenal measurements. As a vasodilator, it was thought to increase GFR. 
Studies have shown that post nephrectomy, intrarenal nitric oxide synthase and 
nitric oxide levels are both reduced, whereas systemic production is increased
43
. 
Indeed the role of nitric oxide in adaptation to nephron loss is not fully understood. 
Bradykinin 
 This vasodilatory peptide is increased in the remnant kidney. Acute and 
chronic infusions of bradykinin increased renal plasma flow but not the GFR. The 
effects of bradykinin on the afferent and efferent are mediated by prostaglandins 
and cytochrome P450 metabolites
44
. Further studies are needed to understand the 
role of bradykinin after nephron loss. 
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Urotensin 
 Urotensin II is the most potent vasoconstrictor identified till date. Urotensin 
II is produced in the kidney and the levels are increased after nephrectomy
45
. 
However the role of urotensin II in adaptation to nephron loss remains to be fully 
elucidated. 
 Alterations in renal auto-regulation 
 Marked readjustment of renal autoregulatory mechanisms are noted after 
renal mass ablation. The role of myogenic mechanisms is believed to be to protect 
the glomerulus from increased systemic blood pressure. The tubuloglomerular 
feedback is also reset to adjust for the increases in the SNGFR
46
. These changes 
are noted as early as 20 minutes after uninephrectomy. 
 
Hypertension 
The current classification of hypertension proposed by the report of the 7
th
 
Joint National Committee is based on the average of two or more properly 
measured, seated BP recordings on each of two or more office visits. This includes 
a new category called ‘prehypertension’ which includes systolic blood pressure 
from 120 to 139 mmHg and diastolic blood pressure from 80 to 89 mmHg. 
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 The stages 2 and 3 of hypertension in the JNC 6 report were combined. The new 
classification proposed in 2003 which is still in vogue is shown in Table 1. 
 
 
About 50 million people in the United States of America suffer from 
hypertension. The incidence and prevalence of hypertension is expected to increase 
in the future. A 90% life-time chance of developing hypertension was noted even 
among people with normal BP at 55 years of age
47
. When the systolic BP increased 
by 20 mmHg and diastolic BP increased by 10mmHg, the risk of cardiovascular 
disease double across the BP range 115/75 to 185/115 mmHg
48
. 
 It was initially thought that diastolic blood pressure was the most important 
predictor of cardiovascular events. Later studies have shown that systolic blood 
pressure is a more important predictor. Therefore the importance of diagnosing 
Isolated Systolic Hypertension (ISH) as a separate category was emphasized. This 
group of patients included those with a systolic blood pressure ≥140 mmHG and a 
normal diastolic blood pressure ≤ 80mmHg. 
BP CLASSIFICATION SBP DBP
NORMAL <120 <80
PRE-HYPERTENSION 120-139 80-89
STAGE 1 140-159 90-99
STAGE 2 ≥160 ≥100
JNC 7 Classification of Hypertension
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Accurate measurement of blood pressure in office 
A calibrated standardized instrument should be used. The auscultatory 
method of BP recording should be followed. At least two measurements should be 
made. The BP recording is done with the person sitting in a chair with arm 
supported at heart level and feet resting comfortably for atleast 5 minutes. A cuff 
bladder encircling at least 80 percent of the arm is an appropriate size. SBP and 
DBP are measured at Korotkoff phases 1 and 5 respectively. 
Hypertension due to renal disease 
Hypertension is common in renal disease. This is especially when the 
disease process affects the vasculature, either inside the kidney or outside. There 
have been a few models to suggest that even essential hypertension could be an 
intrinsic renal disease related to poor sodium excretion. Cross transplantation 
studies have proved that the kidney definitely mediates persistent systemic 
hypertension. When the kidney of the normo-tensive person from a family without 
history of hypertension, was transplanted, hypertensive recipients became normo-
tensive without the need for anti-hypertensive drugs. The glomerulus is sensitive to 
pressure. The intra-glomerular pressure reflects to the systemic BP. Thus 
glomerular diseases tend to present with more severe hypertension. 
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Proteinuria 
Proteinuria  usually  implies  that  there  is  a  defect  in  glomerular  
permeability.  In general, proteinuria can be classified into persistent or transient.  
Among the causes of persistent proteinuria, there are three types:   
(1)  Glomerular proteinuria 
 (2)  Tubular proteinuria 
 (3)  Overflow proteinuria 
  Glomerular proteinuria includes diabetic nephropathy and other common 
glomerular disorders.  It  is  usually  caused  by  increased  filtration  of  
albumin  across  the  glomerular capillary  wall.   
Other  causes  of  glomerular  proteinuria  have  a  rather  benign  course,  such  
as orthostatic  and  exercise-induced  proteinuria.  These  latter  causes  are  
characterized  by significantly  lesser  degrees  of  proteinuria,  ranging  < 2 
g/day.  
 Tubular  proteinuria  is  usually  seen  in  those  with  underlying  
tubulointerstitial  diseases. They  usually  have  defective  reabsorptive  
capacities  in  the  proximal  tubules,  such  that, instead  of  the  proteins  being  
normally  reabsorbed,  they  are  excreted  in  the  urine.  In contrast  to  
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glomerular  proteinuria,  whereby  macromolecules  such  as  albumin  are  
leaked out,  in  tubular  proteinuria  it  is  mostly  low  molecular  weight  
proteins,  such  as immunoglobulin  light  chains,  etc. Proximal tubular injury 
leads to increased low molecular weight proteinuria e.g. intestinal alkaline 
phosphatase, n-acetylglucosaminidase, retinol binding protein, tissue specific 
alkaline phosphatase, α glutathione S transferase, β2 microglobulin and α1 
macroglobulin. β2 microglobulin is freely filtered at the glomerulus and is 
almost completely absorbed in the proximal tubule. Thus it is used as a marker 
of proximal tubular proteinuria. In contrast, Tamm-Horsfall protein and α 
glutathione S transferase are markers of distal tubular proteinuria. Tubular 
proteinuria rarely exceeds 2 grams per day. 
 Overflow proteinuria (also called overproduction proteinuria) is exemplified by 
multiple myeloma, in which there is an overabundance of immunoglobulin light 
chains secondary to overproduction. Simply put, proteinuria occurs as a result 
of the amount of protein produced basically exceeding the maximum threshold 
for reabsorption in the tubules. Dipstick testing may be negative in this case and 
testing for serum electrophoresis and urinary Bence Jones Protein is necessary. 
Other examples include amyloidosis and some reticuloendothelial disorders. 
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          Whereas both glomerular and tubular proteinuria are secondary to 
abnormalities involving the glomerular capillary and tubular walls, respectively, in 
overflow proteinuria, the problem lies in overproduction of certain proteins. 
Quantification  of  the  degree  of  proteinuria  is  accomplished  by  
performing  a  24-hour  urine collection,  which  can  be  cumbersome,  especially  
in  elderly  individuals  or  in  those  with concomitant  fecal  or  urinary  
incontinence. 
The  urine  protein-to-creatinine  (using  a  random  urine  specimen)  ratio  
has  been  shown  to have  a  good  correlation  with  the  24-hour  urine  protein  
determination. 
In  transient  proteinuria  conditions,  there  is  a  transient  change  in  
glomerular hemodynamics causing increased excretion of urinary  protein.  These 
are usually benign and self-limited.  Examples  include  congestive  heart  failure,  
fevers,  strenuous  exercise,  seizure disorders,  and  even  extremes  of  stress.  
Orthostatic proteinuria falls under this category. 
Glomerular proteinuria 
The principal mechanisms of glomerular proteinuria are two. 
1. Increased permeability of glomerular filtration barrier to proteins. 
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2. Incomplete absorption of the filtered protein in the proximal tubule, 
either due to proximal tubular defect or due to the large amount of 
protein filtered. 
The glomerular filtration barrier is both charge and size selective. Therefore a 
defect in either feature will likely result in proteinuria. 
Structure of the glomerular filtration surface  
The three layer concept of the filtration surface includes 
1. Glomerular capillary endothelium 
2. Glomerular basement membrane 
3. Epithelium - podocyte 
Glomerular  endothelial  cells  are  the  most  fenestrated  in  the circulation,  
with  a  pore  area  in  the  peripheral  zone  that  occupies  from  20%  to  50%  of  
the  cell  surface
49
. The glomerular endothelial cells retain cell, but not protein. 
Large proteins are filtered out by the basement membrane. Only water and solutes 
pass through the slit diaphragms of the podocytes. Most of the protein is retained
50
. 
The glycosaminoglycans, glycoproteins and membrane associated proteoglycans or 
glycocalyx form the negative charge on the basolateral surface of the filtration 
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barrier which prevents negatively charged smaller sized proteins from being 
filtered freely.  
Diagnosis of proteinuria 
 Healthy individuals excrete <150mg of protein or <30mg of albumin in 
urine per day. Microalbuminuria is urinary excretion of 30 to 300mg / 24 hours and 
macroalbuminuria is >300mg / 24 hours. Nephrotic range of proteinuria is defined 
as proteinuria >3.5gm/day. Tubular proteinuria rarely exceeds 2gm/day. 
Dipsticks are currently available for rapid screening or urine samples for 
albumin. However they miss out on detecting other significant proteins in the 
urine, like the Bence Jones Protein of multiple myeloma. The copper based Biuret 
method and the dye-binding method using Coomassie brilliant blue as the indicator 
are more sensitive than the commonly used turbidimetric methods like 
sulphosalicylic acid and trichloroacetic acid methods. 
Selectivity of proteinuria 
 Patients with glomerular disease typically have a non selective proteinuria
51
. 
However, minimal change disease caused by fusion of foot processes is 
characterized by selective proteinuria in which albumin is preferentially lost. 
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 The selectivity of proteinuria is measured in the laboratory by comparing the 
clearance of IgG to albumin or tranferrin. Both plasma and spot urine samples are 
required. 
IgG (urine) / IgG(plasma) × transferrin (plasma) / transferrin(urine) 
Selective proteinuria – ratio <0.10 
Non selective proteinuria – ratio >0.20 
Microalbuminuria 
Microalbuminuria is urinary excretion of 30 to 300mg / 24 hours. 
 Radioimmunoassay is the most sensitive method for diagnosis of 
microalbuminuria. It can detect albuminuria >30mg in a normal protein range of 
150mg in a 24 hour urine sample. Microalbuminuria is an independent risk factor 
for not only progression of renal failure but also for increased cardiovascular 
morbidity and mortality. 
Normal urinary protein should not exceed 150 mg/day.  Among  these  
urinary proteins  are  albumin  and  Tamm-Horsfall  mucoproteins  (also  called  
uromodulin).  Urinary dipsticks  only  detect  the  presence  of  albumin;  however,  
they  are  notorious  for  being  poor indicators  of  the  presence  of  urinary  
globulins  and  Bence  Jones  proteins  (commonly  seen in  multiple  myeloma).  It  
is  important  to  recognize  that  the  dipstick  measurement  of  urine protein  is  
57 
 
dependent  on  the  concentration  of  the  urine  specimen  so  that  a  patient  with  
a small  volume  of  concentrated  urine  may  test  21   for  protein,  but  when  a  
24-hour  urine collection  is  obtained  the  actual  daily  concentration  is  much  
smaller.  However, a  patient with  a  large  volume  of  dilute  urine  may  test  
trace  positive  for  protein  but  may  have  a  large amount  of  total  24-hour  
urine  protein  excretion.  Thus, it  is  important  to  quantitate  the amount  of  
proteinuria  found  on  dipstick  testing.  A  more  reliable  test  for  the presence  
of  non-albumin  proteins  is  called  the  sulfosalicylic  acid  test,  which  is  more 
reliable  in  detecting  the  presence  of  albumin,  globulin,  and  Bence  Jones  
proteins  in  the urine,  even  in  low  amounts. 
URINARY DIPSTICKS 
Dipstick Proteinuria(mg/dl) 
Trace 10-30 
1+ 30 
2+ 100 
3+ 300 
4+ ≥1000 
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SULFOSALICYLIC ACID TEST 
Dipstick Appearance Proteinuria(mg/dl) 
Trace Slight turbidity 10-30 
1+ Print visible through specimen 30 
2+ Print invisible 100 
3+ Flocculation 300 
4+ Dense precipitates ≥1000 
 
 
The collection of a 24 hour urine sample for estimation of protein is the best 
method to calculate proteinuria. It nullifies the effect of diurnal variation in urine 
output and proteinuria. However, the method of collection is difficult and changes 
occur with the reagents used for the analysis. So, although it is a gold standard 
method, a repeat testing maybe necessary at times. The procedure is also difficult 
to understand and follow for old people and has its limitations in the out patient 
setting. 
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             The protein-creatinine ratio uses urinary creatinine excretion as a parallel 
marker of proteinuria. It is easy to perform as only a spot urine sample is required. 
The diurnal variations are eliminated. Water intake and urine output do not 
influence the result. Thus it has become a very useful clinical screening test 
 
Spot PCR matches well with the 24 hour sample results. When the spot PCR 
is normal, it effectively rules out the possibility of proteinuria. But the results of 
spot PCR are less reliable in the setting of gross proteinuria and a 24 hour sample 
must be analysed.  Therefore urine spot PCR finds its value as a screening test for 
proteinuria in the outpatient setting.  
 
 
 
 
 
 
 
  
 
MATERIALS  
AND METHODS 
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Materials and Methods 
Setting    : Donors of transplant recipients, 
Department of Nephrology – Out patient 
department 
    Thanjavur Medical College Hospital,  
Thanjavur. 
Ethical committee approval   : Obtained. 
Design of study                        :  Single center, observational study. 
Period of study                     : February - 2012 to October – 2012 
Sample size             : 50 subjects. 
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Selection of study subjects 
Inclusion Criteria 
 Voluntary kidney donors. 
 Related and unrelated donors were included.  
 Both male and female donors were included.  
 No age limits were set. 
 No limits for the time period since donation. 
 Pre-existing diseases or current co-morbid illnesses were accepted. 
Exclusion Criteria 
 No major exclusion criteria were fixed. 
 
Methodology 
The study was carried out in the Nephrology Outpatient Department of 
Thanjavur Medical College Hospital. Voluntary kidney donors of the transplant 
recipients who were attending the Department of Nephrology OPD were traced and 
included in the study. A total of 50 kidney donors were included. All the donors 
who participated in the study were informed about the purpose of the study.  
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The clinical examination and laboratory investigations were done with due consent 
from them. The proforma designed for the study was used for all the subjects and 
the details entered. The name, age and sex, relationship to the recipient, date of 
transplant, blood pressure, blood urea, serum creatinine, urine protein, urine spot 
protein creatinine ratio were documented. The quality of life of the donors was 
assessed by the time taken to return to normal day to day activities after surgery 
and their attitude towards kidney donation.  
The blood pressure measurement was done according to the current 
guidelines for office BP recording, i.e. after min 5 minutes rest, at least 30 min 
after drinking a beverage or smoking. Seated blood pressure recordings were taken 
from both arms. The average of 3 recordings made from each arm taken with at 
least 5 minute interval between two successive recordings from the same arm. 
Auscultatory method of blood pressure measurement and a standard mercurial 
manometer apparatus with appropriate sized bladder cuff was used. 
The serum urea measurement was made by the boiling method and 
creatinine estimated by the jaffe kinetic method in the Department of Biochemistry 
Laboratory, Thanjavur Medical College Hospital. Urine protein was tested by 2% 
suphosalicylic acid. The same were used for urine spot protein creatinine ratio 
estimation.  
  
 
RESULTS OF THE STUDY 
 
 
 
 
RESULTS 
TOTAL NUMBER OF DONORS = 50 
SEX NO. OF DONORS PERCENTAGE 
Male 11 22 
Female 39 78 
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SEX DISTRIBUTION OF DONORS
Age characteristics of the donors studied 
 Youngest donor enrolled    : 32 years 
Oldest donor enrolled    : 74 years 
Mean donor age     : 49 years 
 
Sex-wise age characteristics 
Male donors 
Youngest male donor : 44 years 
Oldest male donor     : 60 years 
Mean age of male donors in the study  : 54.09 years 
Mean age at donation for male donors  : 45.45 years 
Mean post nephrectomy follow up period : 8.63 years 
 
 
 
 Age of male donors studied 
Age No. of donors Percentage 
20-29 0 0 
30-39 0 0 
40-49 3 27.27 % 
50-59 5 45.45 % 
60-69 3 27.27 % 
Age at time of donation – male donors 
Age No. of donors Percentage 
20-29 0 0 
30-39 4 36.36 % 
40-49 2 18.18 % 
50-59 5 45.45 % 
Female donors 
Youngest female donor    : 32 years 
Oldest female donor    : 74 years 
Mean age of female donors in the study : 47.74 years 
Mean age at donation for female donors : 41.74 years 
Mean post nephrectomy follow up period : 6 years 
Age of female donors studied 
Age No. of donors Percentage 
20-29 0 0 
30-39 13 33.33 % 
40-49 7 17.94 % 
50-59 12 30.76 % 
60-69 6 15.38 % 
70-79 1 2.56 % 
  
Age at time of donation -  female donors 
Age  No. of donors Percentage 
20-29 4 10.25 % 
30-39 14 35.89 % 
40-49 10 25.64 % 
50-59 10 25.64 % 
60-69 1 2.56 % 
OVERALL STATISTICS 
AGE AT DONATION NUMBER OF DONORS PERCENTAGE 
20-30 6 12 % 
30-40 16 32 % 
40-50 14 28 % 
50-60 13 26 % 
60-70 1 2 % 
 Least age at donation – 24 years 
 Oldest age at donation – 62 years 
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Age at donation
No. of donors
Relationship of donor to the recipient 
Relationship of donor to 
recipient 
Mother 9 
Father 3 
Brother 6 
Sister 8 
Wife 18 
Mother in law 2 
Father in law 1 
Sister in law 2 
Friend 1 
Total 50 
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Relationship of donor to recipient
  Number of related donors  : 26 
 Shortest post transplant period among related donors  : 1 year 
 Longest post transplant period among related donors      : 27 years 
 Mean post transplant follow up period for related donors   : 8.42 years 
 
 Number of unrelated donors               : 24 
 Shortest post transplant period among unrelated donors        : 7 months 
 Longest post transplant period among unrelated donors           : 22 years 
 Mean post transplant follow up period for unrelated donors  : 4.58 years 
 
Systemic diseases present in donors prior to donation 
Number of donors with pre-existent diseases  : 3 
 Systemic hypertension   : 2 
 Hypothyroidism    : 1 
Systemic diseases developed by the donors after donation 
 Number of donors who developed systemic diseases after donation: 10 
 Systemic hypertension  : 5 
 Diabetes mellitus   : 4 
 Stroke    : 1 
 
Blood pressure 
Systolic blood pressure: 
 Highest systolic blood pressure  : 160 mmHg 
Lowest systolic blood pressure  : 100 mmHg 
 Mean systolic blood pressure  : 122.32±13.65 mmHg 
Diastolic Blood pressure: 
 Highest diastolic blood pressure : 110 mmHg 
 Lowest diastolic blood pressure  : 60 mmHg 
 Mean diastolic blood pressure  : 79.16±9.85 mmHg 
Renal function 
 Serum urea >40mg/dl  : 4 donors 
 Mean serum urea value  : 32.12±5.35 mg/dl 
 Serum creatinine >1.2mg/dl : 1 donor 
 Mean serum creatinine value : 0.91±0.18 mg/dl 
 Proteinuria was not noted in any of the donors. 
 Maximum value of  spot urine protein creatinine ratio: 0.35 
 Mean value of spot urine protein creatinine ratio: 0.18±0.08 
 
Time taken to return to normal life after donation 
Time taken No. of donors Percentage 
2 3 6% 
3 13 26% 
4 18 36% 
5 9 14% 
6 7 18% 
 
  Minimum time taken to return to normal life: 2 weeks 
 Maximum time taken to return to normal life: 6 weeks 
 
 Mean time taken by male donors to return to normal life: 3.63 weeks 
 Mean time taken by female donors to return to normal life: 4.20 weeks 
 Overall mean time taken by donors to return to normal life: 4.08 weeks 
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Discussion 
Living related renal transplantation is the best choice of treatment CKD 
stage V. Increasing number of patients reaching CKD stage V, has intensified the 
demand for expanding the kidney donor pool. Although various studies have 
confirmed the safety of renal donation, it is definitely a major medical, social and 
psychological issue for the live kidney donor who stands at no direct medical 
benefit from the procedure. Studies from India have shown that kidney donors had 
a overall better quality of life after donation
52,53
. So we studied voluntary kidney 
donors in Thanjavur Medical College to ascertain their physical and psychological 
status, so that a confident reply can be given to future volunteers for kidney 
donation. 
Among the 50 donors enrolled in the study, 11 were male and 39 were 
females, constituting 22% and 78% of the study population respectively. 
Muthusethupathi et al. studied renal donors in a state funded hospital in Tamil 
Nadu and found that females constituted up to two thirds of the donor study 
population
54
. The finding of a majority of donors being females was also 
substantiated by Guleria S
53
, in whose study women outnumbered men by a ratio 
of 6:1. Sale of organs in India is legally banned. All the donors we have studied are 
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voluntary donors emotionally related to the recipients and none of them were put 
under pressure to donate a kidney. 
The mean age of the donors studied was 49 years. The youngest donor was 
32 years old and the oldest 74 years old. This finding is similar to other studies on 
donors from India by Guleria et al.
52
 and Sahay et al.
56
. It was shown kidney 
donors live a longer and healthier life than the general population, in a Swedish 
study
55
. Fehrman-Ekholm et al. concluded that renal donors did not have any long 
term risk compared to the general population and that kidney donors appear to live 
longer due the fact that only healthy persons are chosen for kidney donation in 
majority of the circumstances. However, it must be borne in mind that the burden 
of CKD is growing and all individuals therefore, presently stand at a greater risk of 
developing CKD than in the past. This can be attributed to the pandemic of 
diabetes and hypertension, especially so in India which is expected to become the 
diabetic capital of the world. Thus age at donation appears to be important at 
present as younger donors are at a greater risk of developing CKD for the reason 
that they are expected to live longer. 
The youngest male donor was 44 years and the oldest male donor in the 
study was 60 years old. The average age of male donors in the study was 54.09 
years. The mean age at donation for the male donors was 45.45 years. 
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4/11(36.36%) had donated between 30 and 39 years of age. 3/11 (27.27%) were 
between 60 and 69 years of age.  
The youngest female donor was 32 years and the oldest female donor in the 
study was 74 years old. The average age of female donors in the study was 47.74 
years. The mean age at donation for the male donors was 41.74 years. Thus the 
mean age at donation for female donor was nearly 4 years less, compared to male 
kidney donors. 14/39 (35.89%) of female donors had donated between 30 to 39 
years of age and constituted the majority group. 1/39 (2.56%) had donated between 
60 to 69 years of age. 
 4/39 (10.25%) had donated between 20 to 29 years of age. Thus around 
10% of the female donors were in their third decade of their life at the time of 
donation. There were no male donors in that age group. All the 4 female donors in 
the 20 to 29 years age at donation were the wives of recipients. Thus it can be 
surmised that the wives of young men with CKD have opted for transplantation 
readily. This could be for social and economic benefits for the family. The 
intention of the young wives has been to help their husbands reach a better state of 
health and quality of life, who could in turn fend better for the family. Kidney 
donation at very young and very old ages is happening around the world. Sam 
Nagy from Britain, at 20 years of age is the youngest voluntary living kidney 
donor. Britain also houses the oldest donor, Mr. Nicholas Crace at 83 years. A 
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search on the internet for the oldest donor in India shows Mrs. Shailaja Joshi at 74 
years and 7 months as possibly the oldest donor from India. There has also been a 
donor at 72 years. Both were from Mumbai. There could have been older donors, 
who were not reported. In our study the oldest donation was at 62 years. Thus it 
appears that India is trying to match the global scenario for kidney transplantation 
with more expanded criteria living kidney donors being accepted. 
The majority of the donors were wives 18/39 (36%). There were 9 mothers 
(18%) and 8 sisters (16%) among the donors studied. Thus it is evident that 80% of 
the donors in the study were females who were emotionally attached to the 
recipients in the closest order.  
 Our study included 12 parents and 14 siblings. Thus related donors were 
26/50 (52%). Spousal donors were 18 (36%). All were wives. Parents and siblings 
of wives were 5/50 (10%) and 1/50 (2%) was a long time family friend. Therefore 
unrelated donors were 24/50 (48%). The finding of lesser male donors in our study 
is comparable to the findings of Veerappan et al.
57
. 
The mean post transplant follow up period in the related and unrelated 
groups were 8.42 years and 4.58 years respectively. This could have reflected a 
recent increase in unrelated kidney donation. Recently many studies have shown 
that unrelated kidney transplantation has proved to be very successful despite a 
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poor HLA match
17
. In an analysis of living related, unrelated and cadaveric 
transplantations, it was shown that the graft survival rate at 5 years was similar for 
spousal and living unrelated grafts which stood at 75% and 72% with a half life of 
14 and 13 years respectively. For parental living related grafts the 5 year survival 
of the graft was 74% with a half life of 12 years. These were significantly better 
than cadaveric grafts which had a 5 year survival of 62% and a half life of 9 years. 
Thus, a living donor graft performs better then a cadaver graft in any case. It was 
concluded in the study that promoting spousal transplants could remove as many as 
15% of the CKD patients on the UNOS waitlist
17
.  
Parents of CKD patients are often old and may not be fit to donate their 
kidneys. The joint family system is gradually vanishing from our society. With 
shrinking family size, the availability of sibling donors has also come down for 
obvious reasons. Moreover, siblings are also increasingly unwilling to donate. 
When a suitable and willing first degree related donor is not available, the patient’s 
wife comes forward
11
. With the Transplantation of human organs act in 1995, 
spousal donation has become legally permissible in India and has also contributed 
to increasing number of spousal transplants. In the Indian context, especially in 
rural India the husband earns for the family, and the wife wants him to live long. 
There has been a recent surge to include donors with chronic diseases like 
hypertension and diabetes which are well controlled and whose kidneys do not 
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show evidence of injury from the systemic diseases. This is in tune with the ever 
expanding need for kidney donors. The tendency of diabetes and hypertension to 
run in family makes it likely that the donor may suffer from CKD in the longer run. 
Therefore it presently appears reasonable to include these ‘expanded criteria 
donors’ or ‘marginal donors’ with a stricter age criteria. Likewise, the previous age 
limits can be relaxed in donors who are otherwise normal and have no systemic 
diseases when transplantation may offer a better quality of life to the patient, 
without major medical disadvantages to the donor. 
Three of the donors enrolled in the study had systemic diseases prior to 
donation. Two of them had systemic hypertension and one had hypothyroidism. 
They were all under appropriate treatment for the same. It was found that one 
hypertensive donor developed a non fatal cerebrovascular accident one year after 
donation. He is at present ambulant without support and leads an independent life. 
He had not been on regular follow up for control of his systemic hypertension after 
the nephrectomy, till he developed the stroke. We have given appropriate 
medications and counseling to ensure adherence to antiplatelets and 
antihypertensive therapy. The other donor with hypertension at the time of 
donation was a lady 51 years of age at donation and diagnosed with hypertension 
at the time of pre donation screening. She was on regular follow up and 
medications. The donor with hypothyroidism was already on thyroxine 
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supplementation for the past 30 years prior to donation and was in euthyroid state. 
She is continuing to take the same thyroxine dose. 
10 out of the 50 donors studied (i.e. 20%) had present medical ailments. 7 
donors had hypertension. 4 had diabetes mellitus. The male hypertensive donor had 
developed stroke and had a residual hemiparesis with power 4+ and was ambulant. 
The donor with hypothyroidism continued to take thyroxine and was in euthyroid 
state. 
 Prevalence of hypertension is increasing over the years
58
. Nearly 55% of 
males over the age of 50 years were found to be hypertensive in India
59
. A similar 
trend is observed in women over the age of 50 years
59
. However, there is a higher 
prevalence of hypertension in women aged more than 60 years as compared to 
men
59
. In our study, there were 8/11 (72.72%) male donors over the age of 50 
years, and 19/39 (48.71%) female donors were above the age of 50 years. Among 
the donors with hypertension, 2 were hypertensive prior to donation. One donor 
was diagnosed with diabetes mellitus and systemic hypertension by his family 
physician and was on appropriate treatment. He had developed hypertension 5 
years ago, 20 years after donation. The donor with hypothyroidism had developed 
systemic hypertension 1 year back, that is, one year after donation. Another donor 
had developed hypertension 2 years ago. She was diagnosed with hypertension by 
her family physician and was on regular follow up. 2 donors were diagnosed with 
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hypertension for the first time in our study. They were completely asymptomatic 
after donation and had not attended any medical service for follow up or a periodic 
medical check up. None of the donors with hypertension had visited a nephrologist 
after the immediate post transplant follow up. 5 out of the 7 hypertensive donors 
had already been diagnosed with hypertension and were on treatment for the same. 
This reflects the importance of the family physician in the follow up of renal 
donors. All the hypertensive donors were aged more than 55 years. 3 out of the 8 
male donors aged more than 50 years were hypertensive. This averages at 37.5%. 4 
out of the 19 female donors aged more than 50 years were hypertensive. This 
averages 21%. The overall average prevalence of hypertension of 7/50 or 14% for 
the mean age of 49 years and an age adjusted average of 7/27 or 25.92% in donors 
who were aged more than 50 years is lower, compared  with the other community 
based studies on the prevalence of hypertension
59,60
. 
There have been studies to show an increase in prevalence of hypertension 
among kidney donors. Watnick et al 
61
 showed an increase in the occurance of 
hypertension in 1988. They also had observed an increase in glomerular 
proteinuria without a decrement in GFR after up to 18 years post uninephrectomy 
for renal donation. Talseth T et al.
62
 observed a 15% occurrence of hypertension in 
the post donation follow up study. They however understood the increasing 
prevalence of hypertension and concluded that the development of hypertension 
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after donation warrants further observations. Sommerer C et al
63
 in 2004 showed 
that there after age adjustment there was no increase in blood pressure after kidney 
donation. They also had a significantly fewer number of patients with proteinuria. 
Manisha Sahay et al
7
 observed that 46% of renal donors had developed 
hypertension. However, the occurance of hypertension in donors enrolled in our 
study appears to be similar to the general population. All hypertensive donors had 
a good quality of life and none had proteinuria. 
Diabetes mellitus was found in 4 out of the total number of 50 donors 
enrolled. This averaged at 8% for the mean age of the donor study population at 49 
years. There was one male and three female donors with diabetes. The male donor 
with diabetes also had hypertension and was undergoing treatment for both. One 
female donor who had never visited a physician after the immediate post transplant 
follow up was diagnosed with diabetes mellitus for the first time during our study. 
Two other female donors were already diagnosed and were undergoing appropriate 
treatment under their family physicians. 
Proteinuria has been linked to both increased risk of renal and cardiovascular 
diseases. It is used as a marker of endothelial dysfunction. The best technique to 
measure proteinuria is to collect a 24 hour sample and quantify the protein in it. 
This is due to the fact that protein excretion is not uniform throughout the day and 
time based variations in spot urine protein estimations are bound to occur. 
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Creatinine has been used as a marker of clearance since long. It also has variations 
in the rate of excretion. A 24 hour urine protein estimation is time consuming and 
cumbersome. It also causes some practical discomfort to the patients undergoing 
the investigation. To overcome this problem, the estimation of protein to creatinine 
ratio in a spot urine sample was introduced and widely practiced. The concurrent 
estimation of protein and creatinine in a spot sample tends to neutralize the 
variation in excretion of protein. It has been found to be more or less accurate and 
approximates well with the 24 hour protein quantification. Sometimes a spot 
albumin creatinine ratio is used, where available. In our study, we chose to use the 
protein creatinine ratio as a marker of overall proteinuria. The mean protein 
creatinine ratio 0.18± 0.08 (Range 0.04 – 0.35), this is well within the normal of 
0.5 for protein creatinine ratio. None of the donors had demonstrable proteinuria 
by the standard heat coagulation test.  
The mean urea value in our study was 32.12 mg/dl, and the mean creatinine 
value was 0.91mg/dl. The normal range for serum urea values in our lab is 10 to 40 
mg/dl, and for serum creatinine it is 0.6 to 1.2 mg/dl. Concordant higher values for 
both urea and creatinine in a donor were found in 1 donor, who was the 
hypertensive donor without regular follow up. He had a serum urea of 43mg/dl and 
a serum creatinine of 1.5mg/dl. A 74 year old donor 27 years post donation who 
was a normotensive diabetic had serum urea 42 mg/dl and serum creatinine 1.2 
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mg/dl. A 60 year old donor, who became a hypertensive after donation, had serum 
urea 42 mg/dl and serum creatinine 1.1 mg/dl. In all these donors, age, diabetes or 
hypertension seems to pose a risk for developing a decline in renal function. There 
was only one donor, a female of age 40 years, who after 1 year of donation had a 
serum urea of 47mg/dl and serum creatinine of 1.1 mg/dl. She was otherwise 
normal. She had a systolic blood pressure of 110mmHg and diastolic blood 
pressure of 70mmHg. She had no proteinuria in heat coagulation and had a spot 
protein creatinine ratio of 0.08. She has been put on close follow up.  
The average time taken for return to normal life was 4.08 weeks. Among 
female donors it was 4.20 weeks and among male donors it was 3.63 weeks. All 
the donors in our study had undergone conventional surgical nephrectomy. This 
could have led to a slightly longer recovery time. The use of laparoscopic 
nephrectomy, although hastens recovery from the surgery, is associated with a 
higher chance of early graft dysfunction. This may be due to inexperience, 
accidental graft damage during the learning curve, compromised renal blood flow 
due to the prolonged pneumoperitoneum and the chance of having shorter renal 
vessels and multiple arteries. However, in well experienced centres, the outcomes 
with surgical and laparoscopic nephrectomy have become somewhat similar. 
All the donors had a positive attitude toward donation. They were happy to 
have been able to help their near ones get a better life. Most of them were unaware 
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of the need for proper medical follow up. Being asymptomatic, they had continued 
with their usual life. They were all initiated into the post donation follow up 
schedule of periodic medial consultation for screening and were happy to enroll in 
the same. They were willing to advise future prospective donors on the advantages 
of transplantation for CKD and instill confidence based on their good health after 
donation. 
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Limitations of the study 
1. Only about 78 transplant recipients are registered in the Department of 
Nephrology – Transplant OPD in Thanjavur Medical College Hospital. Out 
of them some were cadaver kidney recipients, some had expired, some 
recipients had lost to follow up and some of the donors lived in far away 
places. Only 50 donors could be enrolled in the study. The small number of 
donors studied limits extrapolation of this study into safety profile of donors. 
2. A prospective study would have addressed the donor follow up better. But 
because Thanjavur Medical College Hospital does not offer renal 
transplantation facilities, a prospective study could not be conducted. 
3. The donors enrolled had undergone the transplantation in various centres. 
Most of the centres retained their pre-transplant medical records and were 
not available for comparison with the present values, post donation. 
4. There had not been any graft rejection in any of the recipients. Therefore the 
attitude of all the donors was naturally positive. This may have caused a 
skewed result. 
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Strengths of the study 
1. Although the study has a small sample size of the donors, it seems to 
match the characteristics of larger studies from India with regard to the 
age and sex of the donors. 
2. Donors who had a post donation period ranging from few months up to 
27 years were studied. 
3. The study was conducted in a gentle way, by which the donors 
understood the importance of post donation follow up without being 
alarmed that they were at risk of renal failure. 
 
 
 
 
 
  
  
 
SUMMARY AND 
CONCLUSION 
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Conclusion 
1. There were more female donors than males. 
2. Female donors had a younger age at donation. 
3. A nearly equal number of related and unrelated donors were enrolled. 
4. Wives formed the single major group of donors. No husbands were 
enrolled. 
5. The prevalence of hypertension among donors appears similar to normal 
population. 
6. No donor had developed proteinuria. 
7. No major deterioration in renal function was noted. 
8. Most donors were back to their normal life within a month of donation. 
9. The donors were initiated about post donation follow up. 
10. All the donors had a positive attitude about donation and would reassure 
prospective donors in the future. 
 
  
 
ANNEXURES 
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Abbreviations 
S.no. Abbreviations Expansion 
1 CKD Chronic kidney disease 
2 ESRD End stage renal disease 
3 MDRD Modification of diet in renal disease 
4 GFR Glomerular filtration rate 
5 SNGFR Single nephron glomerular filtration rate 
6 BP Blood pressure 
7 SBP Systolic blood pressure 
8 DBP Diastolic blood pressure 
9 PCR Protein creatinine ratio 
10 HD Hemodialysis 
11 PD Peritoneal dialysis 
12 CAPD Continuous ambulatory peritoneal dialysis 
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Proforma 
Effects of kidney donation 
1. Name       : 
2. Age        : 
3. Sex        : 
4. Date of donation      : 
5. Pre-existing diseases     :     
(Hypertension / Diabetes Mellitus / Renal disease) 
6. Present co-morbidities     :  
7. Blood Pressure      : 
8. Proteinuria:  
1. Qualitative     : 
       2. Spot Protein-Creatinine Ratio  :  
9. Renal function 
1. Urea      : 
2.  Creatinine     : 
10. Impact of donation: 
1. Returned to daily life in   :  ____ weeks 
2. Attitude toward kidney donation  :  
(Positive / Neutral / Negative) 
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